RADIOPHARM THERANOSTICS LIMITED (RAD)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
RAD - RADIOPHARM THERANOSTICS LIMITED
FNArena Sector :
NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: N/A
Index:
FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: N/A
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.04
13 May |
0.000 OPEN $0.04 |
0.000 HIGH $0.04 |
466,029 LOW $0.04 |
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
| Title | 2022 | 2023 |
|---|---|---|
| EPS Basic | xxx | -10.7 |
| DPS All | xxx | 0.0 |
| Sales/Revenue | xxx | 0.3 M |
| Book Value Per Share | xxx | 12.4 |
| Net Operating Cash Flow | xxx | -23.2 M |
| Net Profit Margin | xxx | -11,838.59 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2022 | 2023 |
|---|---|---|
| Return on Capital Employed | xxx | -64.48 % |
| Return on Invested Capital | xxx | -64.48 % |
| Return on Assets | xxx | -43.72 % |
| Return on Equity | xxx | -64.48 % |
| Return on Total Capital | xxx | -74.24 % |
| Free Cash Flow ex dividends | xxx | -23.2 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2022 | 2023 |
|---|---|---|
| Short-Term Debt | xxx | - |
| Long Term Debt | xxx | - |
| Total Debt | xxx | - |
| Goodwill - Gross | xxx | - |
| Cash & Equivalents - Generic | xxx | 12 M |
| Price To Book Value | xxx | 0.80 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2022 | 2023 |
|---|---|---|
| Capex | xxx | 1.5 M |
| Capex % of Sales | xxx | 523.56 % |
| Cost of Goods Sold | xxx | 3 M |
| Selling, General & Admin. Exp & Other | xxx | 37 M |
| Research & Development | xxx | 22 M |
| Investments - Total | xxx | 0 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
0.0
No. Of Recommendations
0
RAD STOCK CHART
FNArena News on RAD
| 1 |
Dr Boreham’s Crucible: Arovella TherapeuticsJul 17 2023 - Small Caps |
| 2 |
Dr Boreham’s Crucible: Radiopharm TheronosticsApr 13 2023 - Small Caps |
| 3 |
Australian Broker Call *Extra* Edition – Mar 21, 2023Mar 21 2023 - Daily Market Reports |
| 4 |
Dr Boreham’s Crucible: Telix PharmaceuticalsAug 22 2022 - Small Caps |